Alzheimer Patients and the Snoezelen Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00548951|
Recruitment Status : Completed
First Posted : October 24, 2007
Last Update Posted : December 16, 2015
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Dementia||Other: Snoezelen Room Other: Control||Phase 1|
The Snoezelen concept or program was originally thought up in Holland and comes from two Dutch words meaning to "sniff and doze". It was first introduced in the Netherlands in the 1970's. The first room was introduced in Snoezelen examines how a group of people react to an area that is private, relaxed and one that they trust. This program will bring out one's sense of taste, touch, smell, sight and hearing just by being in a specially designed room. Trust and relaxation will be looked at by those people with developmental disabilities (those that learn at a slower rate). Snoezelen originated with the belief that everyone needs nerve pulses (senses).
Inside a Snoezelen room you will find, dimmed lights, a relaxed atmosphere and pleasant surroundings, soothing sounds, intriguing aromas, tasty puddings, candies, interesting light effects (fiber optic light spray), comfortable seating, opportunities for interaction and engagement, sense of control over environment, tactile objects (awareness box), bubble tube, solar projector wheel, water fountain, massage pillow, massage tube, tranquility and solitude. The Snoezelen room is an environment in which the primary senses (see, hear, taste, touch) are stimulated all to create an environment that is both relaxing and stimulating. The benefits of Snoezelen change per person but may include some of the following:
- Increased resident and caregiver communication
- Increased awareness and understanding of the environment
The Snoezelen idea: client-controlled, safe comfortable atmosphere and freedom from pressure.
Sensory Deprivation (loss) The average person touches 300 different surfaces every 30 minutes. The average person with a profound disability will likely touch 1-5 surfaces in the same time frame.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||18 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Connection Between Sensory Deprivation and Social Withdrawal in Clients of a Long Term Care Facility Living With Alzheimer's Disease and the Effects of a Snoezelen Program.|
|Study Start Date :||September 2005|
|Actual Primary Completion Date :||December 2006|
|Actual Study Completion Date :||December 2006|
Active Comparator: 1
Subject receives Snoezelen sessions once per week.
Other: Snoezelen Room
Session in a Snoezelen room once per week for 12 weeks
Active Comparator: 2
Subject receives Snoezelen sessions three times per week.
Other: Snoezelen Room
Session in a Snoezelen room three times per week for 12 weeks
Subject receives no sessions per week.
Receive no sessions in a Snoezelen Room.
- To evaluate improvement of the residents who are given Snoezelen sessions. [ Time Frame: 12 weeks ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||65 Years and older (Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- Residents living at Rideaucrest Home (Long Term Care Facility in Kingston, Ontario);
- Residents having a Mini Mental State Exam with a score of 15 to 27 reflecting mild to moderate dementia;
- Male or female over 65 years of age;
- Resident who are able to leave the terrace;
- Resident who are not actively participating in Life Enrichment Programs;
- Able to provide informed written and signed consent by resident or substitute decision maker.
- Suffering from severe life threatening illness with a reasonable expectation of death within the next six month;
- Severe mental disorder in the opinion of the investigator (i.e. bipolar, schizophrenia);
- No recent change in medication(s) during the past four weeks prior to the project;
- Other non-Alzheimer-Type Dementia;
- Residents who suffer from Epilepsy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00548951
|Kingston, Ontario, Canada, K7K 3H6|
|Principal Investigator:||Roumen V. Milev, MD||Queen's University|
|Responsible Party:||Dr. Roumen Milev, Principal Investigator, Queen's University|
|Other Study ID Numbers:||
|First Posted:||October 24, 2007 Key Record Dates|
|Last Update Posted:||December 16, 2015|
|Last Verified:||December 2015|
Central Nervous System Diseases
Nervous System Diseases